Comparison of oral administration of Ergotamine-c and Theophylline on postdural puncture headache in cesarean section

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120915010841N14

Enrollment

Registered

2019-03-12

Start date

2019-01-25

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal anesthesia in cesarean section. Single liveborn infant, delivered by cesarean

Interventions

Intervention 1: Intervention group: Theophylline will be administered at a dose of 100 mg every 8 hours. Intervention 2: Intervention group: Ergotamine-c tablet contain 1 mg of Methyl Ergonovine and 1

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant women who underwent cesarean section under spinal anesthesia and has been a headache. patients with class 1 or 2 according to the American Society of Anesthesiology Lack of systemic disease

Exclusion criteria

Exclusion criteria: sensitivity to medications used Patients who have failed spinal anesthesia and undergo general anesthesia

Design outcomes

Primary

Measure	Time frame
Headache. Timepoint: 24 hours after injection. Method of measurement: visual analgesic scale.	—

Secondary

Measure	Time frame
Nausea & vomiting. Timepoint: after delivery. Method of measurement: Observation.;Dizziness. Timepoint: after delivery. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Nahid Manouchehrian

Hamedan University of Medical Sciences

manouchehrian@umsha.ac+98 81 3827 7012

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 9, 2026